Go to deals
Consumer & Retail

MyDeal.com.au (ASX:MYD) has completed an IPO

MyDeal.com.au Ltd has completed an initial public offering (IPO) to raise US$29.4 million under the ticker ASX:MYD, which values the company at a market cap of approximately US$191 million. The IPO was strongly supported by several well-known institutional investors and family offices, with Morgans and RBC acting as joint lead managers and underwriters.

MyDeal is a pure-play Australian e-commerce retail marketplace specializing in household goods such as furniture and homeware.

Oaklins’ team in Australia acted as corporate advisor in this transaction.

Service
Funding, debt advisory & ECM
Parties
“I worked with the Oaklins team for three years prior to the IPO and sought their advice around M&A opportunities and private raisings. Consequently, they were a natural fit to act as corporate advisor at the IPO. They have always supplied great advice, connections and insight to all aspects of capital markets. The actual IPO had been planned for some time and the team was extremely nimble in changing the parameters to assist us in getting to market not long after COVID-19 hit. I look forward to working with them on the next phase of our journey as a listed company.”

Sean Senvirtne

Founder and CEO, MyDeal.com.au Ltd

Talk to the deal team

 Ryan  Whitelegg

Ryan Whitelegg

Managing Director

Melbourne, Australia
Oaklins Henslow
 Chris  Tait

Chris Tait

Managing Director

Melbourne, Australia
Oaklins Henslow

Related deals

Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.
TMT

Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.

Bigtincan Holdings Limited (ASX:BTH) has raised US$98.6 via a placement and underwritten accelerated non-renounceable entitlement offer.

Learn more
Alice Queen (ASX:AQX) has raised funds via an institutional placement
Other Industries

Alice Queen (ASX:AQX) has raised funds via an institutional placement

Alice Queen Limited (ASX:AQX) has completed a fundraising. The funds will be used to complete the Horn Island Scoping Study, accelerate exploration activities at Horn Island and support working capital. The placement was significantly oversubscribed and strongly supported by a major shareholder, as well as several existing shareholders and new institutional and sophisticated investors.

Learn more
Poolbeg Pharma has completed an Initial Public Offering on AIM
Healthcare

Poolbeg Pharma has completed an Initial Public Offering on AIM

Poolbeg Pharma Plc has raised funds to develop the company.

Learn more